Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 10:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Obesity, Infertility
Interventions: Estradiol, Gonadotropin-releasing hormone (GnRH), Progesterone; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Congenital Heart Block, Neonatal Lupus, Atrioventricular Nodal Dysfunction, Myocardial Injury
Interventions: Dexamethasone or other corticosteroid; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 16 Years to 50 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2008
U.S. locations: 4
States / cities: New Haven, Connecticut • Livingston, New Jersey • New York, New York

Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline (SCD)
Interventions: Virtual Reality (VR) sessions; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 55 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Erectile Dysfunction
Interventions: Sildenafil; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Autosomal-dominant Hyper-IgE Syndrome
Interventions: NDV-3A; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Erectile Dysfunction
Interventions: Udenafil, Placebo; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 19 Years and older · Male only
Enrollment: 618 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 36
States / cities: Birmingham, Alabama • Homewood, Alabama • Mesa, Arizona + 32 more

Conditions: Multiple Sclerosis, Gait Disorders, Neurologic, Cognitive Impairment
Interventions: Dual-task gait, Single-task gait; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Pheochromocytoma, Endocrine Disease, Endocrine Diseases
Interventions: ([18F]-DOPA), ([18F]-6F-DA); Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 3 Years to 120 Years
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2048
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV Infections
Interventions: Cardiac MRI/MRS; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years to 75 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 3
States / cities: Los Angeles, California • Boston, Massachusetts • Dallas, Texas

Conditions: Cognitive Decline
Interventions: Lidocaine, Placebo; Drug
Lead sponsor: Duke University; Other
Eligibility: 50 Years and older
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 2
States / cities: Durham, North Carolina • Norfolk, Virginia

Conditions: High Blood Pressure
Interventions: Nebivolol, Metoprolol XL; Drug
Lead sponsor: Emory University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Older Adults With Cognitive Decline, Older Adults, AI-Based Fitness, Wearables, Cognitive Decline, Physical Activity, Physical Inactivity
Interventions: Fitness app for self-efficacy, Social network via app for social support, Health education app targeting outcome expectations; Other
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 65 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Knoxville, Tennessee

Conditions: Corneal Endothelial Dystrophy, Fuchs Endothelial Corneal Dystrophy, Pseudophakic Bullous Keratopathy, Endothelial Dysfunction
Interventions: TTHX1114(NM141), Vehicle (placebo); Drug · Other
Lead sponsor: Trefoil Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 8
States / cities: Petaluma, California • Jacksonville, Florida • Hoffman Estates, Illinois + 5 more

Conditions: HIV Infections, Dyslipidemia, Endothelial Dysfunction
Interventions: extended release niacin; Drug
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Cerebrovascular Disease, Mild Cognitive Impairment
Interventions: Heart Health Intervention; Behavioral
Lead sponsor: Gregory Jicha, 323-5550; Other
Eligibility: 55 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Cognitive Decline
Interventions: Lion's Mane Study Product; Dietary Supplement
Lead sponsor: M2 Ingredients; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Dementia
Interventions: Flutemetamol F18 Injection, [18F]-RO6958948 Injection, [18F]-MK-6240 Injection; Diagnostic Test
Lead sponsor: Butler Hospital; Other
Eligibility: 50 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Prostatic Neoplasm
Interventions: Restore Rehabilitation Program, Control; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older · Male only
Enrollment: 403 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Non Hodgkin Lymphoma, Heart; Functional Disturbance, Hodgkin Lymphoma, Quality of Life, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
Interventions: Exercise with Trainerize application, Cardiopulmonary exercise testing, MRI scan, Quality of Life Questionnaires, Cognitive and Brain Function Questionnaires, Blood draws; Other · Diagnostic Test · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 85 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Winston-Salem, North Carolina • Richmond, Virginia

Conditions: Bipolar Disorder, Bipolar Depression, Unipolar Depression
Interventions: Lithium, Lamotrigine; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Depression, Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: Miro Health; Other
Eligibility: 60 Years and older
Enrollment: 960 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Sacramento, California • Miami, Florida

Conditions: Prodromal Alzheimer's Disease, Mild Cognitive Impairment, Subjective Cognitive Complaints
Interventions: Digital Memory Notebook (DMN) Application; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Primary Progressive, Multiple Sclerosis (MS) Secondary Progressive, Multiple Sclerosis Acute and Progressive
Interventions: Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibular and dynamic balance., Stretching; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Erectile Dysfunction
Interventions: Device treatment; Device
Lead sponsor: InMode MD Ltd.; Industry
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: New York, New York

Search by objective public record fields.

Estrogen Sensitivity and Ovulatory Dysfunction in Obesity

Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus

Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment

A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects

Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome

Treatment of Erectile Dysfunction I

Measurement and Training of Dual-Task of Gait in Persons With Multiple Sclerosis

Diagnosis of Pheochromocytoma

Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: A Cardiac MRI Study

Lidocaine For Neuroprotection During Cardiac Surgery

The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension

Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline

A Phase 1/ Phase 2 Study of TTHX1114(NM141)

Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels

Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease

Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health

BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors

Improving Exercise Capacity With a Tailored Physical Activity Intervention

PET and MRI Brain Imaging of Bipolar Disorder

The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over

The Digital Memory Notebook

Home Based Functional Balance Intervention for Multiple Sclerosis

Safety and Efficacy of Bi-Polar Radiofrequency for the Treatment of Erectile Dysfunction